id: risky_alcohol_use_to_hepatocellular_carcinoma
name: Risky Alcohol Use â†’ Hepatocellular Carcinoma
from_node:
  node_id: risky_alcohol_use
  node_name: Risky Alcohol Use
to_node:
  node_id: hepatocellular_carcinoma
  node_name: Hepatocellular Carcinoma
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Combined alcohol and HCV exposure creates chronic hepatic inflammation
  and cirrhotic environment'
- 'Step 2: Alcohol-induced oxidative stress generates DNA damage and promotes mutagenesis
  in hepatocytes'
- 'Step 3: Cirrhotic liver provides pro-carcinogenic milieu with altered growth factor
  signaling'
- 'Step 4: Dysplastic nodules undergo malignant transformation to hepatocellular carcinoma'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Paul J Clark et al. 2024. "Alcohol does not impact chronic hepatitis
    C treatment outcomes but increases risk for progressive liver disease: Findings
    from a prospective multicentre Australian study (OPERA-C)." *Drug and alcohol
    review*. https://doi.org/10.1111/dar.13914'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.409780'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: cirrhosis_presence
  direction: strengthens
  strength: strong
  description: Given the high prevalence of cirrhosis in risky alcohol users (45.1%),
    cirrhosis likely serves as an intermediate step that substantially increases HCC
    risk
